论文部分内容阅读
目的探讨阿奇霉素序贯治疗小儿支原体肺炎的临床疗效。方法将60例确诊明确的支原体肺炎患儿随机分为对照组和治疗组。对照组用乳糖红霉素注射剂20~30 mg.kg-1.d-1,每日分2次静脉滴注,连用2~4周;治疗组用阿奇霉素序贯治疗。对两组的临床疗效进行对比分析。结果对照组总有效率为83.0%,治疗组总有效率为100.0%。结论阿奇霉素序贯治疗小儿支原体肺炎有效、安全,值得临床推广。
Objective To investigate the clinical efficacy of azithromycin sequential therapy in children with mycoplasma pneumonia. Methods Sixty children with confirmed mycoplasma pneumonia were randomly divided into control group and treatment group. Control group with lactose erythromycin injection 20 ~ 30 mg.kg-1.d-1, 2 times a day intravenous infusion, once every 2 to 4 weeks; treatment group with azithromycin sequential treatment. The clinical efficacy of the two groups were compared. Results The total effective rate of the control group was 83.0%, the total effective rate of the treatment group was 100.0%. Conclusion Sequential azithromycin treatment of children with mycoplasma pneumonia is effective and safe, worthy of clinical promotion.